Advances in Inflammatory Bowel Diseases is dedicated to the interests of the entire community of IBD patients and is designed to meet the educational needs of all healthcare professionals who treat and manage patients with inflammatory bowel diseases.
We believe the growth and success of Advances in IBD comes from our dedication to offering a comprehensive scientific agenda that is clinically relevant, scientifically state of the art, and the most effective in addressing the educational needs of attendees, while always remaining focused on the goal of enhancing the lives of patients with inflammatory bowel diseases.
2002: Imedex launches the Advances in Inflammatory Bowel Diseases conference in New York, New York, chaired by Dr. Richard MacDermott.
2003: The conference moves to a new location: Chicago, Illinois.
2004: Dr. Stephen Hanauer joins AIBD as Co-Chair. The conference grows to an attendance of more than 300, with presentations by 24 faculty experts.
2005: AIBD heads for warmer climates, relocating to southern Florida. Under the successful leadership of the esteemed Co-Chairs and developing a world-class program, AIBD continues to grow to record numbers.
2006: For the first time, Advances in Inflammatory Bowel Diseases breaks the 500 attendee ceiling.
2008: In just two short years, AIBD doubles its attendance to more than 1,000.
2014: Fast forward to 2014, and AIBD, having outgrown all of the surrounding venues, relocates to Orlando, Florida. With 64 faculty experts, more than 100 educational presentations, and 296 abstracts, AIBD educates more than 1,900 attendees in its new home.
2016: Once again, Imedex's AIBD conference continues to host a record number of attendees who flock to the conference to network with their colleagues, experience cutting-edge education, and learn state-of-the-art methods for improving patient care.
2018: First-time-ever AIBD attendees join in an inspiring celebration of the Sherman Prize honorees for their outstanding work and dedication in the field of IBD.
2019: Dr. Millie D. Long joins as Co-Chair.
Imedex, an HMP Company, is an industry leader in the creation of independent, accredited medical education for healthcare professionals that improves patient care around the world. With an emphasis in oncology, hematology, and gastroenterology, the company develops high-quality scientific programming that translates the latest research into clinically relevant information. Imedex provides more than 50,000 e-learning experiences annually and since 2001, its live conferences have welcomed more than 100,000 attendees. The company operates in the United States, Europe, and Asia. For more information, visit imedex.com.
HMP is the force behind Healthcare Made Practical and is a multichannel leader in healthcare events and education, with a mission to improve patient care. The company produces accredited medical education events and clinically relevant, evidence-based content for the global healthcare community across a range of therapeutic areas. Its brands include Consultant, the monthly award-winning journal relied upon by primary care providers; Psych Congress, the largest independent mental health meeting in the U.S.; EMS World Expo, North America's largest EMT and paramedic event; and the Symposium on Advanced Wound Care (SAWC), the largest wound care meeting in the world. HMP is supported by its lead investor, Susquehanna Growth Equity, LLC (SGE). For more information, visit hmpglobal.com.